Literature DB >> 1349198

Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium.

L A Farrer1, K M Grundfast, J Amos, K S Arnos, J H Asher, P Beighton, S R Diehl, J Fex, C Foy, T B Friedman.   

Abstract

Previous studies have localized the gene for Waardenburg syndrome (WS) type I to the distal portion of chromosome 2q, near the ALPP locus. We pooled linkage data obtained from 41 WS type I and 3 WS type II families which were typed for six polymorphic loci on chromosome 2q in order to refine the location of the WS locus (WS1) and evaluate the extent of genetic heterogeneity. In the course of this work, we developed diagnostic criteria for genetic and phenotypic studies. Our findings, based on two-locus and multilocus analysis using a linkage map established from reference pedigrees, suggest that there are two or more mutations causing WS, one of which (i.e., WS1) is located on chromosome 2q, between the ALPP and FN1 loci, at distances of 7.8 cM and 11.2 cM for each marker, respectively. The results also indicate that WS1 is responsible for the illness in approximately 45% of all families in this sample. However, the odds favoring this position over a location between ALPP and SAG are only 2:1 when alternate assumptions about the proportion of linked families are considered. We conclude that a more saturated map of this region of chromosome 2q, including highly polymorphic markers, will be needed to accurately distinguish linked families and, ultimately, isolate the mutant gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349198      PMCID: PMC1682585     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  48 in total

1.  A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness.

Authors:  P J WAARDENBURG
Journal:  Am J Hum Genet       Date:  1951-09       Impact factor: 11.025

2.  A frequent HindIII RFLP of the human fibronectin gene (FN1).

Authors:  M Colombi; R Gardella; S Barlati
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

3.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Childhood deafness in southern Africa. An aetiological survey of 3,064 deaf children.

Authors:  S Sellars; P Beighton
Journal:  J Laryngol Otol       Date:  1983-10       Impact factor: 1.469

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  An algorithm to improve the computational efficiency of genetic linkage analysis.

Authors:  M S Braverman
Journal:  Comput Biomed Res       Date:  1985-02

7.  Structural and evolutionary relationships among five members of the human gamma-crystallin gene family.

Authors:  S O Meakin; M L Breitman; L C Tsui
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

8.  Mapping the Wilson disease locus to a cluster of linked polymorphic markers on chromosome 13.

Authors:  A M Bowcock; L A Farrer; L L Cavalli-Sforza; J M Hebert; K K Kidd; M Frydman; B Bonne-Tamir
Journal:  Am J Hum Genet       Date:  1987-07       Impact factor: 11.025

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37.

Authors:  D Martin; D F Tucker; P Gorman; D Sheer; N K Spurr; J Trowsdale
Journal:  Ann Hum Genet       Date:  1987-05       Impact factor: 1.670

View more
  52 in total

Review 1.  Waardenburg syndrome.

Authors:  A P Read; V E Newton
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

2.  Identification of a Novel De Novo Variant in the PAX3 Gene in Waardenburg Syndrome by Diagnostic Exome Sequencing: The First Molecular Diagnosis in Korea.

Authors:  Mi-Ae Jang; Taeheon Lee; Junnam Lee; Eun-Hae Cho; Chang-Seok Ki
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

3.  Waardenburg syndrome type 2.

Authors:  Subhash Chandra Shaw; Shekhar Neema; Amit Devgan; Rakesh Maggon
Journal:  Med J Armed Forces India       Date:  2017-07-17

4.  Waardenburg syndrome: A rare case with bilateral congenital cataract: An unusual entity.

Authors:  Nitin Vichare; N Bhargava
Journal:  Med J Armed Forces India       Date:  2012-12-01

5.  Anisometropic amblyopia in a case of type 2 Waardenburg syndrome.

Authors:  Ali Akal; Tugba Göncü; Nurefsan Boyaci; Ömer Faruk Yılmaz
Journal:  BMJ Case Rep       Date:  2013-12-18

Review 6.  The incidence of deafness is non-randomly distributed among families segregating for Waardenburg syndrome type 1 (WS1).

Authors:  R Morell; T B Friedman; J H Asher; L G Robbins
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

7.  Waardenburg-Shah Syndrome: a rare case in an Indian child.

Authors:  Rajesh Pattebahadur; Shipra Singhi; Prafulla Kumar Maharana
Journal:  BMJ Case Rep       Date:  2016-09-30

8.  Exclusion of RET and Pax 3 loci in Waardenburg-Hirschsprung disease.

Authors:  T Attié; M Till; A Pelet; P Edery; J P Bonnet; A Munnich; S Lyonnet
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

Review 9.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

10.  Anaesthesia Management in a Patient with Waardenburg Syndrome and Review of the Literature.

Authors:  Kevser Peker; Julide Ergil; İbrahim Öztürk
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.